Earlier this year, I reported about the potential dangers posed to senior citizens (and others) who were potentially exposed to bacteria from antiseptic wipes. Reports indicate that a child may have died from such exposure and we are aware of seniors who appear to have potentially met the same fate. Now, Federal regulators say that although the New York medical products maker promised in June to recall the product, it has since failed to launch that recall for nearly four months.
Continue Reading

Many times I’ve written about the over-medication of the elderly – especially with anti-psychotics. Despite the fact that anti-psychotics are supposedly only for a small percentage of the elderly, many nursing home residents with dementia are given these drugs even though some have FDA warnings of an increased risk of death. This overuse of anti-psychotics was confirmed in a recent government audit.
Continue Reading

According to The Wall Street Journal, new study published in Archives of Neurology, “showed that about half of elderly Parkinson’s patients with psychosis were prescribed an antipsychotic.” This is despite the fact that in 2005, the FDA issued a “black box” warning to antipsychotics due to an increase in risk of death in older dementia patients. “Black box” warnings are the strongest warnings given by the FDA and are placed on drugs where medical studies indicate that a drug carries a significant risk of serious or life threatening adverse effects.
Continue Reading

The Triad Group has initiated a voluntary recall for several of their products, including alcohol prep pads, alcohol swabs and alcohol swabsticks. The recall includes sterile and non-sterile products produced by Triad Group and was initiated due to concerns from a customer about potential contamination. The products are thought to contain an objectionable organism, Bacillus cereus. The Triad Group is issuing the recall in order to ensure that they are not the source of the contamination issues.
Continue Reading

Although psychotropic drugs are often used to control behavioral symptoms in nursing-home residents, recent data points out that these drugs are given to close to 2/3 of the dementia patients currently residing in nursing homes across the country and have devastating effects. The data states that prolonged use of these drugs leads to a greater risk of adverse effects and even death.
Continue Reading

People with a loved one in a nursing home often become drug experts. Drugs such as Risperdal, Ativan, and Zyprexa are frequently used in nursing homes, and not always for the right reasons. Even though it is not allowed under Federal law or the New Jersey Responsibilities of Nursing Homes Statute, N.J.S.A. 30:13-3(f), nursing homes may use psychotropic drugs as “chemical restraints” simply to save time, make residents compliant, and for convenience of the staff. This can be especially true in understaffed facilities.
Continue Reading

Theresa Walters, of Pennsauken, New Jersey, has been charged with conspiracy, distribution and possession of drugs and distribution in a school zone after police learned that she had been selling prescription drugs to residents at Sterling Manor Nursing Home in Maple Shade, New Jersey. Walters worked at Sterling Manor where she sold and offered to sell drugs to several people at the facility. It is not clear how many residents were offered the drugs or how many bought them.
Continue Reading

We wanted to inform the readers of our blog that the Mass Tort Team of Stark & Stark is now reviewing possible claims against the popular osteoporosis drug, Fosamax. Patients who used Fosamax have reported serious side effects from the drug, including Osteonecrosis of the Jaw (also known as Fossy Jaw, Dead Jaw and Phossy Jaw), low-energy femur fractures and severe and painful injuries affecting bones, joints and muscles.
Continue Reading